Genome-wide significant SNPs for meat L*15 min and a*15 min. by Jiahong Sun (6497603)

Linear trends estimated through the diff-in-diff regression models in the most hit area (group A) and in the control group of municipalities (group B). by Chiara Cadeddu (12554994)

Linear trends estimated through the diff-in-diff regression models in the most hit area (group A) and in the control group of municipalities (group B). by Chiara Cadeddu (12554994)

Linear trends estimated through the diff-in-diff regression models in the most hit area (group A) and in the control group of municipalities (group B). by Chiara Cadeddu (12554994)

Linear trends estimated through the diff-in-diff regression models in the most hit area (group A) and in the control group of municipalities (group B). by Chiara Cadeddu (12554994)

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Authority Groups. by David Vagni (8060432)

Subjects:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Clarity Groups. by David Vagni (8060432)

Subjects:

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Stepwise linear regression model for CIMT with disease duration, disease course, and EDSS as possible predictors, adjusted for age and BMI. by Elyar Alizadeh Najmi (20291071)

Cross-sectional dependence results. by Ozlem Kutlu Furtuna (20308206)

Subjects:

Autocorrelation test results. by Ozlem Kutlu Furtuna (20308206)

Subjects:

Pesaran’s CADF test results for Model I. by Ozlem Kutlu Furtuna (20308206)

Subjects:

Descriptive statistics of related variables. by Ozlem Kutlu Furtuna (20308206)

Subjects:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects: